Resibufogenin administration prevents oxidative stress in a rat model of human preeclampsia

  • Hypertens Pregnancy. 2012;31(1):70-8. doi: 10.3109/10641955.2010.525275.
Mohammad Nasir Uddin  1 ,  Enoch E Agunanne ,  Darijana Horvat ,  Jules B Puschett
Affiliations
  • 1. Department of Medicine, Division of Nephrology and Hypertension, Texas A&M Health Science Center College of Medicine and Scott & White Memorial Hospital, Temple, TX, USA.
PMID: 21174582 DOI: 10.3109/10641955.2010.525275
Abstract

Background and objectives: Marinobufagenin (MBG) is a cardiotonic steroid that is increased in preeclampsia. An analog of MBG, resibufogenin (RBG), prevents the development of preeclampsia in a rat model. Oxidative stress is a concomitant of endothelial dysfunction in the latter disorder. The objective of the current studies was to evaluate the status of oxidative stress in a rat model of preeclampsia.

Methods: We measured the aortic AT(1) receptor expression and urinary excretion of 8-isoprostane (8IP) in rats rendered "preeclamptic" and compared the findings to those obtained in normal pregnant Animals, pregnant rats injected with MBG, and preeclamptic rats treated with RBG.

Results: Aortic AT(1) receptor expression and the urinary excretion of 8IP were significantly augmented in "preeclamptic" and MBG-injected pregnant rats compared to normal pregnant Animals. RBG prevented evidence of oxidative stress in "preeclamptic" rats.

Conclusion: MBG is involved in the causation of oxidative stress in our rat model and RBG attenuates this change.

Products